Evidence map›Paper›PMID 30904859›Full record

ArticleBMJ open2019

LUCSO-1-French pilot study of LUng Cancer Screening with low-dose computed tomography in a smokers population exposed to Occupational lung carcinogens: study protocol.

Fleur Delva, François Laurent, Christophe Paris, Milia Belacel, Patrick Brochard, Olivier Bylicki, Christos Chouaïd, Benedicte Clin, Jean-Dominique Dewitte, Véronique Le Denmat and 6 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03562052 (LUng Cancer Screening With Low-dose Computed Tomography in a Population Exposed to Occupational Lung Carcinogens), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03562052 recruitingnot on this mapstarted 2021, after this paper: background citation

LUng Cancer Screening With Low-dose Computed Tomography in a Population Exposed to Occupational Lung Carcinogens

Typeobservational_patient_registrySponsorCentre Hospitalier Intercommunal CreteilRan2021 to 2031Enrolled6,000ConditionsLung Cancer
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. What is next for occupational cancer epidemiology?Scandinavian journal of work, environment & health · 2022
    Article
  6. Article
  7. Lung Cancer Screening in Asbestos-Exposed Populations.International journal of environmental research and public health · 2022
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

Fleur DelvaService de médecine du travail et de pathologies professionnelles, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.ORCID 0000-0001-5594-5405
François LaurentService de médecine du travail et de pathologies professionnelles, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Christophe ParisCentre Hospitalier Universitaire de Rennes, Rennes, France.
Milia BelacelCentre Hospitalier Intercommunal de Creteil, Creteil, Île-de-France, France.
Patrick BrochardCentre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Olivier BylickiDepartment of Pneumologie, Hopital d'Instruction des Armees Percy, Clamart, France.
Christos ChouaïdCentre Hospitalier Intercommunal de Creteil, Creteil, Île-de-France, France.
Benedicte ClinCentre Hospitalier Universitaire de Caen, Caen, France.
Jean-Dominique DewitteCentre Hospitalier Régional Universitaire (CHRU) de Brest, Brest, France.
Véronique Le DenmatCentre Hospitalier Régional Universitaire (CHRU) de Brest, Brest, France.
Jean-François GehannoCentre Hospitalier Universitaire de Rouen, Rouen, France.
Aude LacourtEPICENE, INSERM U1219, Bordeaux, France.
Jacques MargeryDepartment of Pneumologie, Hopital d'Instruction des Armees Percy, Clamart, France.
Catherine Verdun-EsquerService de médecine du travail et de pathologies professionnelles, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Simone Mathoulin-PélissierInstitut Bergonie, Bordeaux, France.
Jean-Claude PaironPneumologie et pathologie professionnelle, Centre Hospitalier Intercommunal de Créteil, Créteil Cedex, France.
Centre Hospitalier Universitaire de Bordeaux · FRInserm · FRCentre Hospitalier Régional Universitaire de Brest · FRHôpital d'instruction des Armées Percy · FRHôpital Intercommunal de Créteil · FRCentre Hospitalier Universitaire de Caen Normandie · FRCentre Hospitalier Universitaire de Rennes · FRCentre Hospitalier Universitaire de Rouen · FRInstitut Bergonié · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGuidelines concerning the follow-up of subjects occupationally exposed to lung carcinogens, published in France in 2015, recommended the setting up of a trial of low-dose chest CT lung cancer screening in subjects at high risk of lung cancer.

objectiveTo evaluate the organisation of low-dose chest CT lung cancer screening in subjects occupationally exposed to lung carcinogens and at high risk of lung cancer. METHODS AND ANALYSIS: This trial will be conducted in eight French departments by six specialised reference centres (SRCs) in occupational health. In view of the exploratory nature of this trial, it is proposed to test initially the feasibility and acceptability over the first 2 years in only two SRCs then in four other SRCs to evaluate the organisation. The target population is current or former smokers with more than 30 pack-years (who have quit smoking for less than 15 years), currently or previously exposed to International Agency for Research on Cancer group 1 lung carcinogens, and between the ages of 55 and 74 years. The trial will be conducted in the following steps: (1) identification of subjects by a screening invitation letter; (2) evaluation of occupational exposure to lung carcinogens; (3) evaluation of the lung cancer risk level and verification of eligibility; (4) screening procedure: annual chest CT scans performed by specialised centres and (5) follow-up of CT scan abnormalities. ETHICS AND DISSEMINATION: This protocol study has been approved by the French Committee for the Protection of Persons. The results from this study will be submitted to peer-reviewed journals and reported at suitable national and international meetings. TRIAL REGISTRATION NUMBER: NCT03562052; Pre-results.

Indexed as

SmokersAgedCarcinogensEarly Detection of CancerFemaleFranceHumansLung NeoplasmsMaleMiddle AgedOccupational ExposurePilot ProjectsRadiation DosageRisk AssessmentRisk FactorsTomography, X-Ray ComputedCarcinogenslung neoplasmsmass screeningoccupational exposuretomography scanners, X-ray computed

Identifiers

PMID30904859
PMCPMC6475342
OpenAlexW2942862014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.